Cynomolgus LILRA6/CD85b/ILT8 Protein, Accession: A0A2K5VN04

/在： /经由过程：
  • 产物概述
  • 产物规格
  • 运输及存储
  • 品牌申明

    • 产物概述

    产物描写

    Recombinant Cynomolgus LILRA6/CD85b/ILT8 Protein is expressed from HEK293 with His tag at the C-terminal.It contains Gly41-His474.

    Biotinylated

    产物规格

    靶点

    LILRA6/CD85b/ILT8

    份子又名

    Accession

    种属

    Cynomolgus

    卵白序列

    Gly41-His474

    份子量

    The protein has a predicted MW of 48.28 kDa. Due to glycosylation, the protein migrates to 68-75 kDa based on Tris-Bis PAGE result.

    活性

    产物标签

    C-His

    抒发体系

    HEK293

    纯度

    > 95% as determined by Tris-Bis PAGE;> 95% as determined by HPLC

    内毒素

    Less than 1EU per ug by the LAL method.

    运输及存储

    产物表面

    Lyophilized

    运输前提

    Shipped at ambient temperature.

    制剂

    Lyophilized from 0.22um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization.

    复溶

    Centrifuge tubes before opening. Reconstituting to a concentration more than 100 ug/ml is recommended. Dissolve the lyophilized protein in distilled water.

    存储和不变性

    Reconstituted protein stable at -80°C for 12 months, 4°C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 该乙酰乙酸的产品ChemWhat是Watson的公司品种，由Watson受权上海海角社区 在国内世界城市利于，.